Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow
Authors:
- Peng-Yu JiaPJPeng-Yu Jia
- Bao-Jun ChenBCBao-Jun Chen
- Yan ChenYCYan Chen
- Hang YuHYHang Yu
- Yao YuYYYao Yu
- Hui-Min YangHYHui-Min Yang
- Da-Lin JiaDJDa-Lin Jia
- Chun-Yan MaCMChun-Yan Ma
- 27 June 2017
- journal article
- Published by S. Karger AG in Cardiology
- Vol. 138 (3) , 141-146
Abstract
Background: It has been reported that coronary slow flow (CSF) is associated with acute myocardial infarction, ventricular tachycardia, ventricular fibrillation, and even sudden cardiac death. Although studies concerning the etiopathogenesis of CSF are scarce, diffuse atherosclerosis and endothelial dysfunction are thought to play important roles. It has been suggested that a high plasma thrombomodulin (TM) level seems to play an important role in the pathogenesis of atherosclerosis and endothelial dysfunction. Objectives: We hypothesized that a high plasma TM level might be associated with CSF and aimed to research the relationship between plasma TM level and CSF. Methods: Fifty-two CSF patients with angiographically proven CSF and 44 cases with normal coronary flow were included in this study. Coronary flow velocity was determined by the thrombolysis in myocardial infarction (TIMI) frame count method. Plasma TM levels were measured in all the study subjects. Results: Plasma TM levels were significantly higher in the CSF group compared to the control group (3.9 ± 0.5 vs. 3.6 ± 0.3 ng/mL, p = 0.01). There was a positive relationship (r = 0.31, p = 0.002) between plasma TM level and mean TIMI frame count (TFC). Factors associated with mean TFC were plasma TM level (β = 0.206, p = 0.038) and red cell distribution width (β = 0.088, p = 0.009) in multiple linear regression analysis. Conclusions: Patients with CSF have a higher plasma TM level, and this may play an important role in the pathogenesis of CSF. An elevated plasma TM level may be a predictor of CSF. Future studies are needed to confirm these results.Keywords
This publication has 29 references indexed in Scilit:
- Coronary Slow Flow Phenomenon Leads to ST Elevation Myocardial InfarctionKorean Circulation Journal, 2013
- Defining the Coronary Slow Flow PhenomenonCirculation Journal, 2012
- Does coronary slow flow phenomenon lead to myocardial ischemia?International Journal of Cardiology, 2009
- Coronary Slow Flow Phenomenon and Risk for Sudden Cardiac Death Due to Ventricular Arrhythmias: A Case Report and Review of LiteratureClinical Cardiology, 2007
- The Coronary Slow Flow Phenomenon – A New Coronary Microvascular DisorderCardiology, 2002
- Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atheroscierosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort studyThe Lancet, 1999
- Expression of Thrombomodulin in Atherosclerotic Lesions and Mitogenic Activity of Recombinant Thrombomodulin in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteriesCatheterization and Cardiovascular Diagnosis, 1996
- Thrombomodulin is present in human plasma and urine.Journal of Clinical Investigation, 1985
- Angina pectoris and slow flow velocity of dye in coronary arteries—A new angiographic findingAmerican Heart Journal, 1972